If you may be in danger, call or text 988. Call 911 for emergencies. More crisis resources
For education, not medical advice. Always talk with your own doctor or prescriber about your treatment.

Cymbalta vs Effexor

How duloxetine and venlafaxine compare, two SNRI antidepressants.

How they're similar

Duloxetine and venlafaxine are both serotonin-norepinephrine reuptake inhibitors, usually shortened to SNRIs. That means they act on two chemical messengers in the brain, serotonin and norepinephrine. They share a long list of features.

  • They work the same way, by acting on both serotonin and norepinephrine so more of each stays available between nerve cells.
  • They follow the same timeline. Early side effects can show in the first week or two, while the fuller effect on mood and anxiety usually takes four to six weeks, sometimes up to eight.
  • Both are effective for depression and anxiety.
  • Both can raise blood pressure.
  • Both can cause discontinuation symptoms if stopped abruptly, so both need a careful, slow taper planned with a prescriber.
  • Both cause sexual side effects, and those tend to last as long as the medication is taken.
  • Both can increase the risk of bleeding and bruising, especially alongside NSAIDs such as ibuprofen, aspirin, or blood thinners.
  • Both can rarely cause low blood sodium, which is more common in older adults.
  • Both carry the antidepressant boxed warning about a possible increase in suicidal thoughts in people under 25, especially early in treatment.
  • Both must not be combined with MAOI antidepressants, and both have been available as inexpensive generics for years.

How they differ

The differences are real but specific. Duloxetine carries chronic pain approvals that venlafaxine does not, and venlafaxine is especially known for pronounced discontinuation symptoms. The table below sums up the core points, with more detail underneath.

Duloxetine (Cymbalta) Venlafaxine (Effexor)
Drug class SNRI SNRI
FDA-approved uses Major depressive disorder, generalized anxiety disorder Major depressive disorder, generalized anxiety disorder, social anxiety disorder, panic disorder
Also approved for chronic pain Yes, including diabetic nerve pain, fibromyalgia, and chronic musculoskeletal pain No, not formally approved for pain
Discontinuation if stopped Can cause discontinuation symptoms, requires a slow taper Discontinuation symptoms are especially pronounced, even after a missed dose, requires a particularly slow taper
Blood pressure Can raise blood pressure Can raise blood pressure, and the effect is more clearly dose-related
Notable caution Liver caution, generally avoided in significant liver disease or heavy alcohol use No equivalent liver caution

The most practical difference is chronic pain. Duloxetine is FDA-approved for several pain conditions, including diabetic peripheral nerve pain, fibromyalgia, and chronic musculoskeletal pain such as long-standing low back pain or osteoarthritis pain. Venlafaxine acts on the same chemical messengers and is sometimes used off-label for pain, meaning for a purpose the label does not formally list, but it is not formally approved for it. For someone whose depression or anxiety comes alongside ongoing pain, that distinction often points to duloxetine as the simpler one-medication choice.

The next big difference is discontinuation. Both can cause discontinuation symptoms if stopped abruptly, but venlafaxine's are especially pronounced and can come on quickly. Some people notice dizziness, brief electrical "brain zap" sensations, flu-like feelings, or mood changes after even a missed dose, because venlafaxine is short-acting and the level in the body falls quickly. Duloxetine can also cause these symptoms, and it also needs a careful taper, but the effect is generally less abrupt. Either way, stopping is planned with a prescriber and done slowly. For venlafaxine in particular, the taper is often longer and more gradual than people expect.

Both can raise blood pressure, but the pattern differs. Venlafaxine's effect is more clearly dose-related, meaning it grows as the dose goes up and is more prominent at higher doses. At lower doses venlafaxine acts mostly on serotonin, much like an SSRI, and its norepinephrine effect builds with the dose. For someone who already has high blood pressure, or who is likely to need a higher dose, a prescriber may check blood pressure before starting and during treatment, and that monitoring matters more with venlafaxine.

There is one liver caution. Duloxetine has been linked, rarely, to liver injury, so it is generally avoided in people with significant liver disease or heavy alcohol use. Venlafaxine does not carry that specific caution. For someone with a history of liver problems, or who drinks heavily, that single point can tip the choice toward venlafaxine.

The two also differ in anxiety approvals. Venlafaxine has broader anxiety approvals, including generalized anxiety disorder, social anxiety disorder, and panic disorder. Duloxetine is approved for generalized anxiety disorder. If the anxiety condition being treated is social anxiety or panic disorder, venlafaxine is approved for it directly.

Side effects compared

The everyday side effects of these two medications overlap closely. Both can cause nausea and other stomach effects, dry mouth, dizziness, increased sweating, and changes in sleep. With both, side effects tend to arrive before the benefit, and the stomach-related ones often ease within the first couple of weeks. Taking the dose with food can help with nausea.

The main differences in this area are the ones noted above. Venlafaxine's discontinuation symptoms are more pronounced, and its blood pressure effect is more clearly dose-related. Duloxetine carries the rare liver caution. Both can rarely trigger serotonin syndrome, a reaction caused by too much serotonin activity, most likely when either drug is combined with other medications that raise serotonin. If a side effect is severe, or it is not improving after a few weeks, that is a conversation to have with a prescriber rather than a reason to stop on your own.

Sleep, weight, and sexual effects

For sleep, weight, and sexual effects, the two are broadly similar.

Both are roughly weight-neutral, and some people lose a little appetite early on. Both can disturb sleep for some people and cause drowsiness for others, so a prescriber may adjust the timing of the dose based on how it affects you. Sexual side effects are common with both. They can include lower sex drive, delayed orgasm, and arousal or erection difficulties, and they tend to last as long as the medication is taken rather than fading like nausea does. These effects are worth raising with a prescriber, because there are real options, including a dose change, a switch, or adding another medication to counter them.

Why a clinician might choose one over the other

Because the two are closely related, the choice often comes down to specifics.

A clinician might choose duloxetine when chronic pain is part of the picture, since duloxetine is formally approved for diabetic nerve pain, fibromyalgia, and chronic musculoskeletal pain. Treating depression and pain with one medication is often simpler than layering two. Duloxetine is also a reasonable choice for someone who wants to avoid venlafaxine's pronounced discontinuation symptoms, for example a person with a variable schedule who knows they will sometimes miss a dose.

A clinician might choose venlafaxine for its broader anxiety approvals, which include social anxiety disorder and panic disorder alongside generalized anxiety disorder. Venlafaxine is also the safer fit when liver health or heavy alcohol use is a concern, since it does not carry duloxetine's liver caution. Beyond the medication itself, prior response to a related drug, baseline blood pressure, the dose likely to be needed, and other health conditions all factor into the decision. There is no test that predicts the better fit in advance, so the choice is made on the balance of these specifics.

The bottom line

Duloxetine and venlafaxine are closely related medications. Neither is clearly better. The choice is driven mainly by whether chronic pain is involved, by discontinuation concerns, by liver health and alcohol use, and by the specific anxiety condition being treated. It is a decision to make with a prescriber. It is also common to try one and switch to the other if the fit is not right. A first medication that does not suit someone is a normal step in treatment, not a failure.

Common questions

Can I switch directly from one to the other? A switch between these two SNRIs is common and is usually straightforward, but it is planned by a prescriber. Because venlafaxine in particular causes discontinuation symptoms quickly, the timing of the cross-over matters, and stopping one abruptly is not the way to do it.

Which one is better for chronic pain? Duloxetine. It is FDA-approved for diabetic nerve pain, fibromyalgia, and chronic musculoskeletal pain. Venlafaxine acts on the same messengers but is not formally approved for any pain condition, so for depression or anxiety alongside ongoing pain, duloxetine is often the choice.

Why is venlafaxine harder to stop? Venlafaxine is short-acting, so the level in your body falls quickly between doses. That makes discontinuation symptoms come on readily, sometimes after just a missed dose. The answer is consistent daily dosing and a slow, prescriber-planned taper, often more gradual than with many other antidepressants.

Do both raise blood pressure? Both can. Venlafaxine's effect is more clearly tied to dose, so it tends to be more noticeable at higher doses. A prescriber may check blood pressure before starting and during treatment, especially with venlafaxine or for someone who already has high blood pressure.

Sources

This guide draws on current prescribing information and public health references. It is reviewed for clinical accuracy and updated as guidance changes.

  1. U.S. Food and Drug Administration. Duloxetine prescribing information.
  2. U.S. Food and Drug Administration. Venlafaxine prescribing information.
  3. MedlinePlus, U.S. National Library of Medicine.
  4. National Institute of Mental Health. Mental health medications.

Your next step in The Shrink Network

You are here: PsychiatryRx, the medication education layer of The Shrink Network.

Every site in the network does one job. No matter where you start, we help you find the next step that makes sense.

Medication management at shrinkMD

shrinkMD is the network's independent telepsychiatry practice, founded by our medical editor. It's one option among many. PsychiatryRx runs no ads, sells nothing, and earns no referral fees.

Want to understand more first?

Managing a medication needs a prescriber

Any psychiatric medication has to be started and adjusted by a clinician who can follow you over time. If you don't have a prescriber, our guides section explains the options, including in-person care and telepsychiatry, and how to choose between them.